Malignant Thoracic Neoplasm — Trials

Malignant Thoracic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

11,499 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,775
Recruiting: 1,497
Ph III recruiting: 183
Growth YoY: +6.5%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,528)

clinicaltrialsPublishedShowing 351–400 of 4,486 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07750704	Lorlatinib Plus Sacituzumab Tirumotecan With Peripheral ctDNA Guidance as First-Line Therapy for ALK Fusion-Positive NSCLC	not yet recruiting	Phase 2	153	Guangdong Association of Clinical TrialsOTHER	1	Aug 6, 2026	clinicaltrials
NCT03999710	Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer	active not recruiting	Phase 2	61	Memorial Sloan Kettering Cancer CenterOTHER	1	Aug 5, 2026